Related Experiment Videos
Therapeutical aspects of cerebrovascular disease
European Neurology
|January 1, 1983
Abstract:
Treatment of hemorheologic alterations in patients with CVD must be directed to reduce enhanced platelet and red cell aggregation, to improve reduced red cell deformability, and to control plasmatic hypercoagulability.